4.8 Article

Chitosan-zein nano-in-microparticles capable of mediating in vivo transgene expression following oral delivery

Journal

JOURNAL OF CONTROLLED RELEASE
Volume 249, Issue -, Pages 150-161

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jconrel.2017.01.035

Keywords

Oral delivery; DNA delivery; Zein; Chitosan; Gene therapy; DNA vaccination

Funding

  1. Nebraska Research Initiative
  2. UNL IANR ARD
  3. National Science Foundation [CBET-1254415]
  4. Center for Nanohybrid Functional Materials (NSF) [EPS-1004094]
  5. American Heart Association [10SDG2640217]
  6. University of Nebraska Foundation (Layman Funds)
  7. National Institute of General Medical Sciences of the National Institutes of Health [P20GM104320]
  8. Crohn's and Colitis Foundation of America [3578]
  9. Nebraska Corn Board
  10. UNL Research Council Interdisciplinary Seed Grant
  11. UNL Research Council-Tobacco Settlement Funds Biomedical Seed Grant
  12. USDA CSREES-Nebraska [NEB-21-146, NEB-26-211]
  13. Directorate For Engineering
  14. Div Of Chem, Bioeng, Env, & Transp Sys [1254415] Funding Source: National Science Foundation

Ask authors/readers for more resources

The oral route is an attractive delivery route for the administration of DNA-based therapeutics, specifically for applications in gene therapy and DNA vaccination. However, oral DNA delivery is complicated by the harsh and variable conditions encountered throughout gastrointestinal (GI) transit, leading to degradation of the delivery vector and DNA cargo, and subsequent inefficient delivery to target cells. In thiswork, we demonstrate the development and optimization of a hybrid-dual particulate delivery systemconsisting of two natural biomaterials, zein (ZN) and chitosan (CS), to mediate oral DNA delivery. Chitosan-Zein Nano-in-Microparticles (CS-ZN-NIMs), consisting of core Chitosan/DNA nanoparticles (CS/DNA NPs) prepared by ionic gelation with sodium tripolyphosphate (TPP), further encapsulated in ZN microparticles, were formulated using a water-in-oil emulsion (W/O). The resulting particles exhibited high CS/DNA NP loading and encapsulation within ZN microparticles. DNA release profiles in simulated gastric fluid (SGF) were improved compared to un-encapsulated CS/ DNA NPs. Further, site-specific degradation of the outer ZN matrix and release of transfection competent CS/ DNA NPs occurred in simulated intestinal conditions with CS/DNA NP cores successfully mediating transfection in vitro. Finally, CS-ZN-NIMs encoding GFP delivered by oral gavage in vivo induced the production of anti-GFP IgA antibodies, demonstrating in vivo transfection and expression. Together, these results demonstrate the successful formulation of CS-ZN-NIMs and their potential to improve oral gene delivery through improved protection and controlled release of DNA cargo. (C) 2017 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available